150 related articles for article (PubMed ID: 22661887)
1. Preparation and evaluation of polymeric microparticulates for improving cellular uptake of gemcitabine.
Lim JH; You SK; Baek JS; Hwang CJ; Na YG; Shin SC; Cho CW
Int J Nanomedicine; 2012; 7():2307-14. PubMed ID: 22661887
[TBL] [Abstract][Full Text] [Related]
2. Surface-modified gemcitabine with mucoadhesive polymer for oral delivery.
Lim JH; You SK; Baek JS; Hwang CJ; Na YG; Shin SC; Cho CW
J Microencapsul; 2012; 29(5):487-96. PubMed ID: 22783823
[TBL] [Abstract][Full Text] [Related]
3. Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study.
Hosseinzadeh H; Atyabi F; Dinarvand R; Ostad SN
Int J Nanomedicine; 2012; 7():1851-63. PubMed ID: 22605934
[TBL] [Abstract][Full Text] [Related]
4. Role of chitosan nanoparticles in the oral absorption of Gemcitabine.
Derakhshandeh K; Fathi S
Int J Pharm; 2012 Nov; 437(1-2):172-7. PubMed ID: 22909993
[TBL] [Abstract][Full Text] [Related]
5. N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer.
Chen G; Svirskis D; Lu W; Ying M; Huang Y; Wen J
J Control Release; 2018 May; 277():142-153. PubMed ID: 29548985
[TBL] [Abstract][Full Text] [Related]
6. Superior preclinical efficacy of gemcitabine developed as chitosan nanoparticulate system.
Arias JL; Reddy LH; Couvreur P
Biomacromolecules; 2011 Jan; 12(1):97-104. PubMed ID: 21117615
[TBL] [Abstract][Full Text] [Related]
7. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery.
Amin MK; Boateng JS
Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323455
[No Abstract] [Full Text] [Related]
8. Alendronate-loaded microparticles for improvement of intestinal cellular absorption.
Baek JS; Kwon HH; Hwang JS; Sung HC; Lee JM; Shin SC; Kim YR; Cho CW
J Drug Target; 2011 Jan; 19(1):37-48. PubMed ID: 20477555
[TBL] [Abstract][Full Text] [Related]
9. Mucoadhesive microparticulates based on polysaccharide for target dual drug delivery of 5-aminosalicylic acid and curcumin to inflamed colon.
Duan H; Lü S; Gao C; Bai X; Qin H; Wei Y; Wu X; Liu M
Colloids Surf B Biointerfaces; 2016 Sep; 145():510-519. PubMed ID: 27239905
[TBL] [Abstract][Full Text] [Related]
10. Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery.
Joshi G; Kumar A; Sawant K
Eur J Pharm Sci; 2014 Aug; 60():80-9. PubMed ID: 24810394
[TBL] [Abstract][Full Text] [Related]
11. Loading of Gemcitabine on chitosan magnetic nanoparticles increases the anti-cancer efficacy of the drug.
Parsian M; Unsoy G; Mutlu P; Yalcin S; Tezcaner A; Gunduz U
Eur J Pharmacol; 2016 Aug; 784():121-8. PubMed ID: 27181067
[TBL] [Abstract][Full Text] [Related]
12. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models.
Andreani T; Miziara L; Lorenzón EN; de Souza AL; Kiill CP; Fangueiro JF; Garcia ML; Gremião PD; Silva AM; Souto EB
Eur J Pharm Biopharm; 2015 Jun; 93():118-26. PubMed ID: 25843239
[TBL] [Abstract][Full Text] [Related]
13. Design and evaluation of an intravesical delivery system for superficial bladder cancer: preparation of gemcitabine HCl-loaded chitosan-thioglycolic acid nanoparticles and comparison of chitosan/poloxamer gels as carriers.
Şenyiğit ZA; Karavana SY; İlem-Özdemir D; Çalışkan Ç; Waldner C; Şen S; Bernkop-Schnürch A; Baloğlu E
Int J Nanomedicine; 2015; 10():6493-507. PubMed ID: 26508855
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine-loaded chitosan microspheres. Characterization and biological in vitro evaluation.
Ventura CA; Cannavà C; Stancanelli R; Paolino D; Cosco D; La Mantia A; Pignatello R; Tommasini S
Biomed Microdevices; 2011 Oct; 13(5):799-807. PubMed ID: 21607718
[TBL] [Abstract][Full Text] [Related]
15. Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy.
Khare V; Singh A; Mahajan G; Alam N; Kour S; Gupta M; Kumar A; Singh G; Singh SK; Saxena AK; Mondhe DM; Gupta PN
Eur J Pharm Sci; 2016 Sep; 92():183-93. PubMed ID: 27404580
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of mucoadhesion and permeation enhancement of polymeric amphiphilic nanoparticles.
Liu Y; Di Zang H; Kong M; Ma FK; Dang QF; Cheng XJ; Ji QX; Chen XG
Carbohydr Polym; 2012 Jun; 89(2):453-60. PubMed ID: 24750743
[TBL] [Abstract][Full Text] [Related]
17. Implementation of mixture design for formulation of albumin containing enteric-coated spray-dried microparticles.
Shastri PN; Ubale RV; D'Souza MJ
Drug Dev Ind Pharm; 2013 Feb; 39(2):164-75. PubMed ID: 22591196
[TBL] [Abstract][Full Text] [Related]
18. Site specific/targeted delivery of gemcitabine through anisamide anchored chitosan/poly ethylene glycol nanoparticles: an improved understanding of lung cancer therapeutic intervention.
Garg NK; Dwivedi P; Campbell C; Tyagi RK
Eur J Pharm Sci; 2012 Dec; 47(5):1006-14. PubMed ID: 23041219
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of gemcitabine and simvastatin through PLGA polymeric nanoparticles for the treatment of pancreatic cancer: in-vitro characterization, cellular uptake, and pharmacokinetic studies.
Jamil A; Aamir Mirza M; Anwer MK; Thakur PS; Alshahrani SM; Alshetaili AS; Telegaonkar S; Panda AK; Iqbal Z
Drug Dev Ind Pharm; 2019 May; 45(5):745-753. PubMed ID: 30632800
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Eudragit® L100-coated chitosan-based nanoparticles for oral enoxaparin delivery.
Patriota YBG; Arruda IES; de Jesus Oliveira AC; de Oliveira TC; de Lemos Vasconcelos Silva E; Chaves LL; de Oliveira Silva Ribeiro F; da Silva DA; de La Roca Soares MF; Soares-Sobrinho JL
Int J Biol Macromol; 2021 Dec; 193(Pt A):450-456. PubMed ID: 34688680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
